{"id":"W2947269397","doi":"10.1200/jco.2019.37.15_suppl.6639","title":"A cost-utility analysis of atezolizumab in the second-line treatment of metastatic urothelial carcinoma.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Atezolizumab; Medicine; Docetaxel; Metastatic Urothelial Carcinoma; Cost effectiveness; Taxane; Oncology; Chemotherapy; Cost-effectiveness analysis; Quality-adjusted life year; Internal medicine; Cancer; Bladder cancer; Immunotherapy; Breast cancer; Urothelial carcinoma; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008141515,0.001627973,0.001833882,0.002650827,0.0004160197,0.00209929,0.001500699,0.001661164,0.004087241],"category_scores_gemma":[0.02042857,0.001076431,0.004573697,0.001979574,0.0005935455,0.001421122,0.001270099,0.001989099,0.0002454914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01094116,"about_ca_system_score_gemma":0.005818291,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04498393,"about_ca_topic_score_gemma":0.02614448,"domain_scores_codex":[0.9960496,0.003141699,0.00009474722,0.000182418,0.0002932663,0.0002382336],"domain_scores_gemma":[0.9889789,0.009365931,0.0006216377,0.0001799671,0.0005526058,0.0003010056],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.003376497,0.0003789199,0.007991361,0.0007744883,0.001644231,0.0003094572,0.00006245782,0.9622518,0.0004121978,0.005942369,0.001470018,0.01538624],"study_design_scores_gemma":[0.0008976909,0.001473944,0.006573493,0.000287286,0.001849694,0.0002387807,0.0001549959,0.9823945,0.0002865887,0.003799395,0.001979945,0.0000635204],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.898743,0.01528831,0.04581444,0.004622968,0.0001915722,0.002993846,0.01325248,0.000188481,0.01890492],"genre_scores_gemma":[0.9873151,0.001182451,0.007546464,0.0002446872,0.00002690564,0.000469501,0.001695818,0.00002186012,0.001497252],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04498393,"threshold_uncertainty_score":0.08944416,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2139740202085181,"score_gpt":0.4899264956342296,"score_spread":0.2759524754257114,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}